Published in J Neural Transm (Vienna) on January 16, 2008
The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects (GuaKet) | NCT01600885
A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2009) 2.80
Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.00
Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics. CNS Drugs (2010) 0.99
Genetic aspects in attention-deficit/hyperactivity disorder. J Neural Transm (Vienna) (2008) 0.90
Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives. Eur J Clin Pharmacol (2010) 0.83
Effects of the serotonin transporter (5-HTTLPR) and α2A-adrenoceptor (C-1291G) genotypes on substance use in children and adolescents: a longitudinal study. Psychopharmacology (Berl) (2010) 0.82
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms. Br J Clin Pharmacol (2014) 0.82
Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD. Eur Arch Psychiatry Clin Neurosci (2010) 0.79
Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders. Pharmacogenomics J (2013) 0.79
Sequence analysis of the ADRA2A coding region in children affected by attention deficit hyperactivity disorder. Neurol Sci (2013) 0.79
Association Between 5-HTTLPR Polymorphism and Tics after Treatment with Methylphenidate in Korean Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol (2015) 0.77
Haplotype polymorphism in the alpha-2B-adrenergic receptor gene influences response inhibition in a large Chinese sample. Neuropsychopharmacology (2012) 0.77
Further evidence for the association between attention deficit/hyperactivity disorder and the serotonin receptor 1B gene. J Neural Transm (Vienna) (2009) 0.77
A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study. J Neural Transm (Vienna) (2016) 0.77
The Brazilian contribution to Attention-Deficit/Hyperactivity Disorder molecular genetics in children and adolescents. Genet Mol Biol (2012) 0.76
Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol (2015) 0.75
Genetic Variations in Attention Deficit Hyperactivity Disorder Subtypes and Treatment Resistant Cases. Psychiatry Investig (2016) 0.75
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry (2007) 14.02
Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 7.94
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87
Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry (1996) 3.05
Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry (2005) 3.04
Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience (2005) 1.93
Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct (2005) 1.87
Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry (1999) 1.85
Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry (2005) 1.66
Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations. Pharmacotherapy (2003) 1.57
The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1996) 1.35
A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry (2006) 1.29
Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: a case-control study. J Am Acad Child Adolesc Psychiatry (2006) 1.11
Attention-deficit/hyperactivity disorder pharmacogenomics. Biol Psychiatry (2005) 1.09
Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2007) 1.04
Factors influencing elementary school teachers' ratings of ADHD and ODD behaviors. J Clin Child Psychol (1998) 1.02
The genetics of ADHD: a literature review of 2005. Curr Psychiatry Rep (2006) 0.99
Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Mol Psychiatry (2007) 0.96
The adrenergic receptor alpha-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD. Cogn Affect Behav Neurosci (2006) 0.94
Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder? Am J Med Genet B Neuropsychiatr Genet (2003) 0.93
Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics. Pharmacogenomics (2005) 0.90
Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene. J Hum Genet (2004) 0.85
Association between alpha-2a-adrenergic receptor gene and ADHD inattentive type. Biol Psychiatry (2006) 0.84
Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder. Mol Psychiatry (2006) 0.83
MspI identifies a biallelic polymorphism in the promoter region of the alpha 2A-adrenergic receptor gene. Clin Genet (1997) 0.83
Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80
Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry (2000) 4.34
Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb Cortex (2001) 4.03
Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry (1995) 3.98
Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet (1996) 3.48
Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry (1993) 3.27
A 3-year follow-up of children with and without behavioral inhibition. J Am Acad Child Adolesc Psychiatry (1993) 2.98
Further evidence of association between behavioral inhibition and social anxiety in children. Am J Psychiatry (2001) 2.88
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry (1992) 2.60
Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. Am J Hum Genet (2000) 2.59
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry (1996) 2.54
Stable behavioral inhibition and its association with anxiety disorder. J Am Acad Child Adolesc Psychiatry (1992) 2.31
Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry (1995) 2.22
ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry (1997) 2.09
NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet (1998) 2.09
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry (1999) 2.07
Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand (2004) 2.05
Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry (1999) 2.04
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Arch Gen Psychiatry (1995) 1.97
Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry (1997) 1.96
Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am J Med Genet B Neuropsychiatr Genet (2009) 1.92
Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics (1999) 1.88
Differential heritability of adult and juvenile antisocial traits. Arch Gen Psychiatry (1995) 1.88
Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry (2000) 1.78
Toward a new psychometric definition of social disability in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1996) 1.77
Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy (1997) 1.69
Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry (1997) 1.68
Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry (2009) 1.68
Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry (2000) 1.67
Toward reformulating the diagnosis of schizophrenia. Am J Psychiatry (2000) 1.67
Diagnostic accuracy of the Child Behavior Checklist scales for attention-deficit hyperactivity disorder: a receiver-operating characteristic analysis. J Consult Clin Psychol (1994) 1.65
Restriction site polymorphism in the phosphoglycerate kinase gene on the X chromosome. Hum Genet (1984) 1.65
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant (2008) 1.61
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry (2010) 1.61
Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid-resistant asthma. Allergy (2003) 1.61
Comorbidity between ADDH and learning disability: a review and report in a clinically referred sample. J Am Acad Child Adolesc Psychiatry (1992) 1.61
Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry (1998) 1.60
Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders. Arch Gen Psychiatry (1990) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1995) 1.59
Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis (1997) 1.56
A pilot study of neuropsychological function in girls with ADHD. J Am Acad Child Adolesc Psychiatry (1997) 1.56
Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry (1990) 1.55
Towards understanding the schizophrenia code: an expanded convergent functional genomics approach. Am J Med Genet B Neuropsychiatr Genet (2007) 1.55
Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull (1994) 1.55
Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry (1998) 1.53
Lipidized medulloblastoma in adults. Hum Pathol (1993) 1.50
Patterns of alcohol and drug use in adolescents can be predicted by parental substance use disorders. Pediatrics (2000) 1.50
Convergence of the Child Behavior Checklist with structured interview-based psychiatric diagnoses of ADHD children with and without comorbidity. J Child Psychol Psychiatry (1993) 1.48
Behavioral inhibition in childhood: a risk factor for anxiety disorders. Harv Rev Psychiatry (1997) 1.48
The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry (2011) 1.46
A registry-based twin study of depression in men. Arch Gen Psychiatry (1998) 1.45
Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. J Clin Child Psychol (1998) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia: an MRI-based morphometric analysis. Biol Psychiatry (1999) 1.39
Formation of a thermodynamically metastable structure containing hairpin II is critical for infectivity of potato spindle tuber viroid RNA. EMBO J (1991) 1.38
Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. Am J Addict (1997) 1.37
Methodological complexities in the diagnosis of major depression in youth: an analysis of mother and youth self-reports. J Child Adolesc Psychopharmacol (2001) 1.36
Toward defining a neuropsychology of attention deficit-hyperactivity disorder: performance of children and adolescents from a large clinically referred sample. J Consult Clin Psychol (1997) 1.35
Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res (1994) 1.35
Intake of dioxins and related compounds from food in the U.S. population. J Toxicol Environ Health A (2001) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Genes, environment and schizophrenia. Br J Psychiatry Suppl (2001) 1.33
Evidence of familial association between attention deficit disorder and major affective disorders. Arch Gen Psychiatry (1991) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol (2000) 1.32
The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD. Arch Dis Child (2005) 1.32
Down-regulation of TSH subunit mRNA levels by thyroid hormones in the European eel. Gen Comp Endocrinol (1997) 1.30
Genetic and environmental influences on transitions in drug use. Behav Genet (1999) 1.29
The case for heterogeneity in the etiology of schizophrenia. Schizophr Res (1995) 1.28
Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia. Biol Psychiatry (1994) 1.28
A controlled study of behavioral inhibition in children of parents with panic disorder and depression. Am J Psychiatry (2000) 1.28
Identification of the phenotype in psychiatric genetics. Eur Arch Psychiatry Clin Neurosci (1993) 1.27
Sustained attention deficits as markers of genetic susceptibility to schizophrenia. Am J Med Genet (2000) 1.27
The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study. Psychol Med (2008) 1.26
Genome-wide search for schizophrenia susceptibility loci: the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet (1998) 1.26
Correspondence between DSM-III-R and DSM-IV attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1997) 1.25
The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med (2011) 1.25
Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry (1996) 1.23
Are perinatal complications relevant to the manifestation of ADD? Issues of comorbidity and familiality. J Am Acad Child Adolesc Psychiatry (1993) 1.23
Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry (1998) 1.23
Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry (2003) 1.22
Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD. J Am Acad Child Adolesc Psychiatry (1996) 1.22
Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J Clin Psychiatry (1998) 1.21
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res (2000) 1.19
Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry (1996) 1.19
Patterns of psychopathology and dysfunction in high-risk children of parents with panic disorder and major depression. Am J Psychiatry (2001) 1.19
Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry (1995) 1.18
A controlled family study of children with DSM-IV bipolar-I disorder and psychiatric co-morbidity. Psychol Med (2009) 1.18
Diagnostic continuity between child and adolescent ADHD: findings from a longitudinal clinical sample. J Am Acad Child Adolesc Psychiatry (1998) 1.18
Evidence for the multigenic inheritance of schizophrenia. Am J Med Genet (2001) 1.18
A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry (2008) 1.18
Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers. Biol Psychiatry (2000) 1.18